INSIGHTS ON DRUG DEVELOPMENT

• Advancing Cell Culture Strategies To Accelerate Biologics Development

  Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.

• Accelerate Your pDNA And mRNA Process Development

  Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.

• Facilitate Handling Of Bulk Powders With Dry Granulation

  Handling bulk powders in manufacturing presents serious challenges—from unpredictable caking to safety risks—that can disrupt workflows. Discover solutions to streamline operations and protect your team.

• Matrix Approach Enhances Potency Assay Development For ATMPs

  Potency assays for ATMPs demand precision. Learn how a matrix approach, regulatory alignment, and advanced technologies can overcome variability and ensure safety throughout the product lifecycle.

• How Automation Helps Life Sciences Manufacturers Deliver Faster, Safer Therapies

  6/2/2026

  Automation paired with smart data management is becoming the base for faster drug and vaccine production without trading away quality. Five investment priorities show where manufacturers are concentrating their efforts.

• CRISPR Meets LNPs: A New Era In Cell And Gene Therapies

  7/8/2025

  Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.

• Advancing Infectious Disease Research With This ddPCR System

  3/26/2026

  Efficient digital PCR workflows maximize data from 5µL samples. Achieve high-level multiplexing and faster turnaround times to accelerate discovery and verify NGS findings with total confidence.

• Fast And Scalable Fc Quantitation In Supernatants

  3/24/2025

  In biopharmaceutical development, the Fc PAIA Titer assay offers a fast, cost-effective, and automatable solution for high-throughput Fc quantification to enhance efficiency, support research, and accelerate production advancements.

• EMA Support For SMEs Through Scientific Advice And Early Dialogue

  5/6/2026

  Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and de‑risk innovative programs through early dialogue.